Javascript must be enabled to continue!
The roles of HMGB1‐produced DNA gaps in DNA protection and aging biomarker reversal
View through CrossRef
AbstractThe endogenous DNA damage triggering an aging progression in the elderly is prevented in the youth, probably by naturally occurring DNA gaps. Decreased DNA gaps are found during chronological aging in yeast. So we named the gaps “Youth‐DNA‐GAPs.” The gaps are hidden by histone deacetylation to prevent DNA break response and were also reduced in cells lacking either the high‐mobility group box (HMGB) or the NAD‐dependent histone deacetylase, SIR2. A reduction in DNA gaps results in shearing DNA strands and decreasing cell viability. Here, we show the roles of DNA gaps in genomic stability and aging prevention in mammals. The number of Youth‐DNA‐GAPs were low in senescent cells, two aging rat models, and the elderly. Box A domain of HMGB1 acts as molecular scissors in producing DNA gaps. Increased gaps consolidated DNA durability, leading to DNA protection and improved aging features in senescent cells and two aging rat models similar to those of young organisms. Like the naturally occurring Youth‐DNA‐GAPs, Box A‐produced DNA gaps avoided DNA double‐strand break response by histone deacetylation and SIRT1, a Sir2 homolog. In conclusion, Youth‐DNA‐GAPs are a biomarker determining the DNA aging stage (young/old). Box A‐produced DNA gaps ultimately reverse aging features. Therefore, DNA gap formation is a potential strategy to monitor and treat aging‐associated diseases.
Wiley
Sakawdaurn Yasom
Papitchaya Watcharanurak
Narumol Bhummaphan
Jirapan Thongsroy
Charoenchai Puttipanyalears
Sirapat Settayanon
Kanwalat Chalertpet
Wilunplus Khumsri
Aphisek Kongkaew
Maturada Patchsung
Chutha Siriwattanakankul
Monnat Pongpanich
Piyapat Pin‐on
Depicha Jindatip
Rujira Wanotayan
Mingkwan Odton
Suangsuda Supasai
Thura Tun Oo
Busarin Arunsak
Wasana Pratchayasakul
Nipon Chattipakorn
Siriporn Chattipakorn
Apiwat Mutirangura
Title: The roles of HMGB1‐produced DNA gaps in DNA protection and aging biomarker reversal
Description:
AbstractThe endogenous DNA damage triggering an aging progression in the elderly is prevented in the youth, probably by naturally occurring DNA gaps.
Decreased DNA gaps are found during chronological aging in yeast.
So we named the gaps “Youth‐DNA‐GAPs.
” The gaps are hidden by histone deacetylation to prevent DNA break response and were also reduced in cells lacking either the high‐mobility group box (HMGB) or the NAD‐dependent histone deacetylase, SIR2.
A reduction in DNA gaps results in shearing DNA strands and decreasing cell viability.
Here, we show the roles of DNA gaps in genomic stability and aging prevention in mammals.
The number of Youth‐DNA‐GAPs were low in senescent cells, two aging rat models, and the elderly.
Box A domain of HMGB1 acts as molecular scissors in producing DNA gaps.
Increased gaps consolidated DNA durability, leading to DNA protection and improved aging features in senescent cells and two aging rat models similar to those of young organisms.
Like the naturally occurring Youth‐DNA‐GAPs, Box A‐produced DNA gaps avoided DNA double‐strand break response by histone deacetylation and SIRT1, a Sir2 homolog.
In conclusion, Youth‐DNA‐GAPs are a biomarker determining the DNA aging stage (young/old).
Box A‐produced DNA gaps ultimately reverse aging features.
Therefore, DNA gap formation is a potential strategy to monitor and treat aging‐associated diseases.
Related Results
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
Objectives
Doxorubicin (DOX) is a widely used anti-tumour agent. The clinical application of the medication is limited by its side effect which can elicit myocard...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Abstract
Background: Age-associated epigenetic alteration is the underlying cause of DNA damage in aging cells. Two types of youth-associated DNA-protection epigenetic mark...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Introduction: The United States currently faces two opioid crises, an evolved crisis currently manifesting as widespread abuse of illicit opioids, and a crisis in pain management l...
High-mobility group box 1 (HMGB1) mediates DNA methylation preventing genomic instability
High-mobility group box 1 (HMGB1) mediates DNA methylation preventing genomic instability
Global DNA hypomethylation promotes genomic instability through the accumulation of DNA damage and resulted in an increasing rate of mutation. To stabilize the genome, cells posses...
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Abstract
Autophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis. However, the underlying mechanisms remain unclear. High mobility ...
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract
Malignant mesothelioma (MM) is a very aggressive cancer that causes 2000-3000 deaths annually in the U.S. and is resistant to current therapies. Diagnosis f...
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the ...
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Abstract
BACKGROUND: Sjögren's syndrome (SS) is a common chronic inflammatory autoimmune disease, affects about 0.33% to 0.77% population in China. The positive for antinuc...

